Tag - Platelet BioGenesis

Platelet BioGenesis Receives $56 Million Contract from BARDA

Ziad2022-11-25T14:03:26-05:00 Platelet BioGenesis Receives $56 Million Contract from the Biomedical Advanced Research and Development Authority (BARDA) to Develop Human Stem Cell-Derived Platelets as a Medical Countermeasure to Radiological and Nuclear Exposure. Read more >>

Platelet BioGenesis Raises $26 Million

Ziad2022-11-25T14:03:26-05:00 Platelet BioGenesis Inc. said Sept. 9 that it raised more than $26 million in a Series A round co-led by Ziff Capital Partners and Qiming Venture Partners USA. Read more >>

Platelet BioGenesis Signs Lease for New Headquarters in Watertown, Mass.

Ziad2022-11-25T14:03:27-05:00 Platelet BioGenesis, Inc. (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, today announced that it has signed a lease for 18,000 square feet of lab space at 65 Grove Street in the emerging biotech hotbed of Watertown, Mass. Read more >>

Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer

Ziad2022-11-25T14:03:37-05:00 Platelet BioGenesis (PBG), the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the hiring of Sam Rasty, Ph.D., as President and CEO. Read more >>

VC Funding Update: 45 Startups Raise Over $542 Million in June

Ziad2022-11-25T14:03:37-05:00 Another summer starts with a bang for Boston startups, which raised over $500 million in June. Read more >>

Platelet BioGenesis Augments Board of Directors with Oncology and Immunotherapy Industry Leader Richard Murray, Ph.D.

Ziad2022-11-25T14:03:38-05:00 Platelet BioGenesis, the leader in stem cell-derived, on-demand human platelets (PLTs+™) and platelet-based therapeutics, announced today the addition of Dr. Richard Murray, president and CEO of Jounce Therapeutics, to its board of directors. Read more >>

Exclusive: Platelet Biogenesis Eyes Entering the Clinic, Doubling Employment This Year

Ziad2022-11-25T14:03:38-05:00 The polar vortex that brought bone-chilling temperatures to much of the United States earlier this winter highlighted a near constant concern – an inadequate supply of platelets at blood centers across the country. Read more >>

Platelet Biogenesis and Scaled Biolabs to Collaborate to Optimize Platelet Production Platform

Ziad2022-11-25T14:04:54-05:00Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, and Scaled Biolabs (Scaled) announced the two firms are collaborating to optimize PBG’s unique production process for making human platelets, or PLTs+™. The agreement was announced at the SynBioBeta 2018 biology summit. Read more >>

Platelet BioGenesis Moves to New Cambridge Lab Space to Support Continued Growth

Ziad2022-11-25T14:04:54-05:00Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+™) from stem cells and the development of platelet-based therapeutics, announced it has moved into brand new lab space in Cambridge, MA. Located next to MIT, the newly renovated property puts Platelet BioGenesis in the heart of the most dynamic biotech cluster in the world. Read more >>

Platelet BioGenesis Receives $3.5 Million Grant from Department of Defense

Ziad2022-11-25T14:04:55-05:00Cambridge, Massachusetts-based Platelet Biogenesis was awarded a two-year, $3.5 million grant from the U.S. Department of Defense. The funds are to support the company’s proprietary bioreactor to produce therapeutic amounts of platelets. Read more >>